Charles (Chuck) leads the COPILOT team, which advises life science organizations on creating functional reimbursement HUB services. He has over 25 years of bio-pharmaceutical industry experience, including responsibility for strategic reimbursement, pricing, payer strategy, product distribution, medical communications, payer marketing and HEOR modeling. Also, Chuck has specialized expertise in Hematology, Oncology, Infectious Disease, Addiction Medicine, CNS, OA and rare disorder products. He has worked extensively on healthcare policy issues and was a member of a bio-pharmaceutical consortium that successfully advocated for CMS expansion of recognized drug compendia, supporting reimbursement and patient access to therapy in Oncology.

Prior to joining COPILOT, Chuck worked at ICON where he served as the President of MediMedia/CHC and head of global access & commercialization, responsible for a team of over 400 life science consultants. Previous to that, he was the Vice President & General Manager of PAREXEL’s reimbursement HUB, health policy and market access consulting practice. Before joining PAREXEL, he held commercial positions of increasing responsibility at Cephalon Oncology, Cell Therapeutics, Genetics Institute (Wyeth Oncology) and Abbott Laboratories.

Chuck graduated from Northeastern University, has an MBA from Clark University and a Juris Doctor Degree from Suffolk University Law School. He attended the Massachusetts Senior Executive Program at Harvard University’s John F. Kennedy School of Government, and is a former Captain in the United States Army and a veteran of Operation Desert Storm. Chuck is admitted to practice before all courts in Massachusetts and the Supreme Court of the United States of America. He is a frequent presenter at international conferences including the FDA/CMS Summit, DIA and the Financial Times Drug Pricing Summit, and has been quoted in Barrons, PharmaVoice, FDA Week and the Pink Sheet. He is a past member of the government affairs committee of NASP (National Association of Specialty Pharmacies) and of ISPOR’s (International Society for Pharmacoeconomics and Outcomes Research) Institutional Council & CER (Comparative Effectiveness Research) Workgroup.

Education

Graduated from Northeastern University.

MBA from Clark University.

Juris Doctor Degree from Suffolk University Law School.

Dr. Moby Kazmi is the President and Co-Founder of COPILOT. In this role, he has led the development of some of the most innovative bio-pharma reimbursement HUB solutions which have been specifically designed to overcome access to treatment barriers and improve patient outcomes. Under Moby’s leadership, COPILOT has continued to provide clients with efficient and effective patient reimbursement and clinical support services, illustrated by COPILOT’s 95% same day completion rate of patient benefit verifications. Dr. Kazmi has played an integral role in helping to develop COPILOT’s digital platform and was instrumental in the development of a design that provides healthcare professionals and bio-pharma clients with instantaneous data regarding patient insurance approval. His work has led to COPILOT’s services becoming a cornerstone in the commercial success of many essential drug and device products.

As part of COPILOT, Moby established and drives COPILOT Cares, a charitable initiative that benefits underprivileged children and families around the world through a variety of philanthropic efforts. One of COPILOT Cares’ key investments is the installation of hand pumps for clean water where access is lacking. To date, COPILOT Cares has installed more than 400 hand pumps in India, Bangladesh, Pakistan, and Sri Lanka, providing clean water to families on a global scale.

Prior to this, Moby co-founded CareMed Specialty Pharmacy. It quickly gained recognition as one of the nation's fastest growing, privately held companies by Inc. Magazine. By December 2013, annual sales surpassed $250MM. PharMerica, a leading provider of pharmacy services, acquired CareMed in March 2017.

In 2021, the Orlando Business Journal announced Dr. Kazmi as one of its "CEOs of the Year", an honor shared by top executives in the region who make both an economic and community-wide impact. Moby was also recently recognized as one of the National Minority Quality Forum’s top “Forty Under 40” Leaders in Minority Health, due to his achievements in eliminating health disparities. He serves on the Board of Directors for AdventHealth for Children (formerly Florida Hospital for Children), Bali Memorial Trust and Helping Hands Foundation. In addition, he has received several citations from the New York State Senate, the New York State Assembly, the Towns of North Hempstead and Oyster Bay, NY, MLB NY Mets’ Spirit Award, and Entrepreneur and Philanthropist of the Year Award from the Friends for Good Health Organization. He was recognized by the Nassau County Executive for his entrepreneurship, philanthropy, and service as a global goodwill ambassador as well. Moby earned his Medical Doctorate Degree from Avalon School of Medicine and his undergraduate degree in Psychology from Stony Brook University.

Education

Bachelor of Science in Psychology from SUNY Stony Brook.

Medical Doctorate from Avalon School of Medicine.

Matt demonstrates value across multiple areas including client relations, account management and business development. During his seven years at COPILOT, his leadership has supported the launch and transition of many HUB programs and has helped COPILOT rapidly become a leader in reimbursement HUB services.

Prior to COPILOT, Matt was an account management executive at CMO Club, where he was responsible for managing billion dollar brand engagement and maintaining C-suite relationships. He also gained extensive healthcare marketing experience supporting client engagement at Medidata Solutions and Palio Communications (Syneos). Matt has supported many brands across a variety of disease categories including Osteoarthritis, Dermatology, Pain Management, Diabetes and Urology. He actively supports COPILOT’s clients, overseeing a team of dedicated professionals who work to make the client integration process seamless, on time and on budget. Matt is a graduate of Roger Williams University in Bristol, RI.

Education

Graduated from Roger Williams University in Bristol, RI.

Caleb began his career in health policy working for the Massachusetts Legislature, and drafted legislation that expanded healthcare access and prescription drug benefit to seniors. He next served as a Special Assistant at the Centers for Medicare and Medicaid Services (“CMS”) in Washington DC. In this position, he advised the Offices of Regulatory Affairs and Administrator on payment policy, and managing the clearance of all regulations within the U.S. Department of Health and Human Services, the White House’s Office of Management and Budget, and the Office of Federal Register.

Upon leaving CMS in 2005, DesRosiers spent five years in the life science industry—Pfizer, and Roche—supporting brand teams cross-functional payment policy, advocacy, managed care and commercial initiatives. Since 2010, DesRosiers has provided strategic market access, and payment policy advisory consulting to life science and healthcare technology companies. DesRosiers is currently the Commercial Operations Advisor at COPILOT spearheading business development, marketing, and policy. In addition, he is a Senior Principal at Valuate Healthcare Consultancy—a company of Entrée Health a leading market access agency within Omnicom Healthcare Group and its parent company Omnicom Group (NYSE: OMC).

Prior to his executive roles at COPILOT, and Valuate, Caleb was the Chief Strategy Office of PrescribeWellness, a pharmacy SaaS company, and was the EVP of Payer Relations and Legal Affairs at CareMed Specialty Pharmacy—a company of PharMerica, where he successfully advised the founders on strategic partnership initiatives.

DesRosiers serves on the board of Daxor Corporation (NASDAQ: DXR), the Health Alliance Plan of Michigan—a company of Henry Ford Health System, and advisory board of TruLite Health, and Brightwood Capital Advisors. He served on the boards of Affinity Health Plan, Health Pointe of New York, Trusted Health Plan of Michigan, the Primary Care Development Corporation, and advisory board of PrescribeWellness.

Education

B.A. in Public Administration & Law from Suffolk University.

Master’s in Public Administration & Law from Suffolk University.

Scott heads up the COPILOT Finance team, bringing nearly 30 years of healthcare and life science industry experience to the organization. He has served in a variety of financial leadership roles across various aspects of the industry on both the service and support side, as well as R&D and commercial manufacturing. He will be providing financial leadership, direction and analysis across the organization, as COPILOT grows and supports it’s life science partners through the creation of functional reimbursement HUB services.

Prior to joining COPILOT, Scott was the Sr. Director of Financial Planning and Analysis at Marinus Pharmaceuticals, providing financial direction, insight, and analysis and scenario modeling for the successful launch of Marinus’ first commercial product Ztalmy. Scott also served in a similar role at Strongbridge Biopharma as Director of FP&A, also in the rare disease biopharmaceutical arena, prior to Strongbridge’s acquisition by Xeris Pharmaceuticals in 2021.

Before joining Strongbridge and subsequently Marinus, Scott worked at ICON Clincal Research where he served as Division Principal - Finance for the global access & commercialization organization, responsible for all financial aspects of the group, including budgeting, forecasting, reporting and KPI analysis. This role at Icon was the result of Icon’s acquisition of Medimedia Pharma Solutions. Scott served as the Vice President of Finance and Controller at Medimedia Pharma Solutions for twelve years prior (Medimedia’s Market Access and Scientific Communications organization) driving double digit, year over year, growth for 10+ years, ultimately resulting in the successful sale to ICON Clinical Research for $120M in 2015.

Prior to Medimedia, Scott served as a financial leader at Johnson & Johnson and Wyeth (Pfizer) in a variety of responsibilities and began his career in Audit at PriceWaterhouse (now PWC).

Education

Graduate Degree from Bucknell University.

Bachelor’s Degree in Business Administration and Accounting from Bucknell University.

MBA from Fairleigh Dickinson University in Marketing.

Alicia is an expert in commercial patient hub operations and new product launches with over 10 years of global experience in creating, developing, and managing patient assistance programs in multiple therapeutic areas.

Prior to coming to COPILOT, Alicia’s most recent experience includes her expertise in the cell and gene space. While at Kite, A Gilead Company, Alicia was a key player for the development of the end-to-end process, patient enrollment to product delivery, of getting the first approved CAR-T therapy for adults to transplant centers both in the US and ex-US. At Gamida Cell, Alicia was responsible for creating and overseeing end-to-end patient journey, with supporting operational efficiencies, leading the project management of system and process validations in preparation of FDA submission.

Alicia is committed to continuing her journey in improving operational efficiency in patient services and creating unique developments to ensure speed to therapy for patient access. She is a patient advocate in her community, with the goal of decreasing the gap in the health disparities.

Education

Graduated with B.S. degree in Health Education from The University of Central Arkansas.

M.S. in Health Administration/Education from The University of Central Arkansas.

Marlon is an accomplished business development executive with extensive experience in patient and pharmaceutical services. At COPILOT, he leads the Business Development team and is responsible for developing and executing sales strategies, building relationships with life science companies and strategic partners, and driving business growth.

Marlon has over 25 years of experience in the healthcare industry, focusing on pharmaceuticals, biotechnology, specialty pharmacy, infusion management, and patient support services. He is a results-oriented leader who delivers innovative solutions that improve patient outcomes. In addition, Marlon's extensive provider and patient-centric commercial launch and leadership experience make him an asset to COPILOT.

Before joining COPILOT, Marlon worked at AmerisourceBergen's LASH Group and Biopharma Services as Vice President of Business Development, Strategic Account Management, Sales Operation, and Sales Enablement. Marlon has also worked at AppianRx, a manufacturer of patient support services and specialty pharmacy provider, where he served as SVP of Sales & Marketing. Before that, Marlon was the Vice President of Commercial Operations at Iroko Pharmaceuticals and has held other senior commercial leadership roles at Allergan (Map Pharma), Sunovion, and Rhone-Poulenc Rorer.

Education

Master of Science in Strategic Management from Stevens Institute of Technology, Hoboken, NJ.

Undergraduate degree in Marketing from Seton Hall University, South Orange, NJ.

Judy has worked with COPILOT’s senior leadership team for nearly a decade, originally joining CareMed Specialty Pharmacy in 2011. She began as a Recruiting Assistant and went on to become the Human Resources Staffing Manager. She transitioned to COPILOT in 2017 and helped expand the Human Resources department, developing recruitment, onboarding and training processes to support HUB operations.

Judy is responsible for staffing, engagement and benefits. She leads the development and strategic placement of personnel. She guides the Human Resources team, manages relationships between leaders and all levels of staff, ensures compliance and advises on all employment matters.

Prior to COPILOT, she was an event coordinator and coached children in educational sports programs. Judy studied writing, literature, and the arts at Brandeis University, and The New School in New York. She uses her strong communication, creativity and baking skills to lift spirits, raise awareness for charitable causes and positively impact the company and the surrounding community.

Education

Graduated in writing, literature, and the arts from Brandeis University, and The New School in New York.

Anne Chiotti, Pharm.D is the Clinical Pharmacist of COPILOT Provider Support Services in Scottsdale, AZ. In addition to managing all non-dispensing pharmacy operations, Anne provides support to clients, healthcare professionals, and patients through leading the development of adherence support programs for HUB products. Having lost two young cousins and countless loved ones to Cancer over the past 2 decades, she finds passion in providing patient care services to those relying on specialty medications (especially those with Oncology indications).

This inspired her work as a Pharmacist at the Yuma Regional Cancer Center in Yuma, AZ and as a Pharmacy Intern at The James Cancer Hospital and Solove Research Institute in Columbus, OH. She holds a Doctor of Pharmacy from The Ohio State University, a M.S. degree from Roswell Park Cancer Institute (Buffalo, NY) and a B.S. degree in Pharmaceutical Science from The State University of New York at Buffalo.

Education

Doctor of Pharmacy from The Ohio State University.

M.S. degree from Roswell Park Cancer Institute (Buffalo, NY).

B.S. degree in Pharmaceutical Science from The State University of New York at Buffalo.